Developer docs
API playgroundTry for free, no card

Search company profiles

Cryotec Global

Full company profile

uuid0047t7f

Namestring
Cryotec Global
Legal namestring
Reprolife Inc.
Websiteurl
cryotec.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Cryotec Global, operating commercially as REPROLIFE Inc., is a Japanese-based company that develops and commercializes vitrification and warming technology for oocyte and embryo cryopreservation in the assisted reproductive technology (ART) market. Its core technology is built on proprietary vitrification/warming protocols originated by Dr. Masashige Kuwayama, and is delivered through a tiered product line: the original Cryotec system, a Ready-to-Use (RtU) consumable variant launched in September 2022, and Cryotec Pro, a premium upgrade launched at ESHRE 2025 in June 2025. The company also publishes comparative clinical evidence, most notably a study reporting a 52.55% pregnancy rate versus 48.99% for a competing brand across 1,041 embryos at 13 Japanese clinics.

The company operates a B2B go-to-market model, selling devices and consumables to fertility clinics worldwide, with stated distribution or commercial coverage across seven major global regions. Its commercial motion is heavily conference-driven, with recurring presence at ESHRE, ASRM, and MEFS, and an explicit "Challenge 100" clinic-acquisition initiative suggesting an active push to broaden adoption. There is no disclosed revenue, funding, headcount, M&A activity, or senior leadership change, and no AI/ML components are integrated into the product offering. The commercial story is therefore one of a focused, founder-led ART consumables/device vendor expanding product tier and international reach on a relatively narrow financial footprint.

Short descriptiontext

Cryotec Global (DBA: REPROLIFE Inc.) is a Japanese company that develops vitrification and warming technology for oocyte and embryo cryopreservation, selling a tiered Cryotec product line directly to fertility clinics worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
Markets served

Serves global market

Keyword5 values
vitrification solutions, embryo cryopreservation, oocyte freezing kits, IVF lab products, ART cryopreservation
Industry3 codes
PRIMARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
SECONDARYHLAAAJAN
Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
NAICS code2 codes
  • Biological Product (except Diagnostic) Manufacturing325414
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Biological Products, (No Disgnostic Substances)2836
Product category
Reproductive Medicine Cryopreservation
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Cryotec Product Sales
TypeHardware Sales
Description

Sale of Cryotec vitrification and warming products including Ready to Use kits, to fertility clinics and embryology laboratories worldwide.

reprolife.jp
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Cryotec RtU
Description

Cryotec Ready to Use - vitrification and warming kits for oocytes and embryos featuring pre-dispensed solutions and simplified protocols.

reprolife.jp
+1 more record
Core offering1 text field

Cryotec Global develops and sells proprietary vitrification and warming kits for the cryopreservation of oocytes and embryos used by fertility clinics, IVF centers, and embryology laboratories. Its flagship Cryotec Ready to Use (RtU) line features pre-dispensed, low-toxicity cryoprotectant solutions and a unified protocol applicable to cells of any stage, with clinical data demonstrating higher pregnancy rates than competing products.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Cryotec Ready to Use achieved 52.55% pregnancy rate vs 48.99% for competing brand (3.56 percentage point improvement) in study of 1,041 embryos across 13 Japanese clinics
Product overview1 text field

Cryotec Global, through its brand Reprolife, offers a unified product portfolio centered on the Cryotec vitrification and warming method for reproductive cells. The core offering includes the Cryotec method/product line, Cryotec Ready to Use (RtU) kits with pre-dispensed solutions, and Cryotec Pro. These products share a unified protocol that applies to oocytes and embryos at any stage, featuring simplified procedures and high survival rates. The portfolio is designed to serve embryologists in fertility clinics worldwide, with clinical validation data demonstrating superior pregnancy outcomes compared to competing solutions.

Product and service3 records
1Cryotec
CategoryReproductive Medicine Cryopreservation
Description

Cryotec is an innovative vitrification and warming method and product line for oocytes and embryos, featuring simplified protocols, embryologist-friendly product designs, and a unified protocol applicable to cells of any stage. It is developed for fertility clinics and embryology laboratories.

2Cryotec Ready to Use (RtU)
CategoryReproductive Medicine Cryopreservation
Description

Cryotec Ready to Use is a pre-dispensed vitrification and warming kit that eliminates the need for manual solution preparation. Clinical data from 13 clinics in Japan (September 2022 - April 2024) demonstrated a 52.55% pregnancy rate compared to 48.99% with competing products, a 3.56 percentage point improvement. It targets fertility clinics, IVF centers, and embryology laboratories.

3Cryotec Pro
CategoryReproductive Medicine Cryopreservation
Description

Cryotec Pro is an advanced Cryotec product line for reproductive cryopreservation, announced and showcased at ESHRE 2025 in Paris. Specific features and capabilities were not detailed in the source material.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major manufacturer of IVF/ART media, including cryopreservation solutions, as part of a much broader cell culture and bioprocessing portfolio. Competes with Cryotec in vitrification media while serving adjacent markets with greater scale.

TypeEmerging player
Description

UK-based manufacturer of ART devices and consumables including embryo transfer and cryopreservation products. Comparable as a niche ART equipment supplier targeting the same fertility clinic customer base with adjacent device offerings.

TypeDirect peer
Description

Provider of precision instruments, consumables, and software for the ART and reproductive medicine market. Overlaps with Cryotec in serving embryologists and IVF clinics with workflow tools, though more focused on laser and imaging instruments.

TypeDirect peer
Description

Japan-based developer of the Cryotop vitrification method, the most widely used oocyte and embryo cryopreservation system globally. Direct competitor in ART cryopreservation consumables with similar target customers and product category.

TypeBroad incumbent
Description

Large women's health and fertility company offering ART consumables, devices, and genomics services to clinics globally. Overlaps with Cryotec in fertility clinic consumables but operates as a broad incumbent across multiple reproductive medicine categories.

TypeDirect peer
Description

Australian-based ART device and consumables company offering products including vitrification tools for fertility clinics. Direct competitor targeting the same embryologist customer base with workflow-focused ART solutions.

TypeDirect peer
Description

Swedish IVF media and cryopreservation solutions provider serving fertility clinics worldwide. Competes directly with Cryotec in vitrification and warming media for oocytes and embryos, with a broader portfolio across the IVF workflow.

TypeDirect peer
Description

German manufacturer of ART media and cryopreservation solutions for IVF clinics. Direct competitor offering comparable vitrification and warming products to the same embryologist customer segment, particularly strong in Europe.

9LifeGlobal Group
TypeDirect peer
Description

Provider of IVF media, including vitrification solutions, sold to fertility clinics worldwide. Competes directly with Cryotec in oocyte and embryo cryopreservation media, with comparable single-use kit offerings.

10Cook Medical
TypeBroad incumbent
Description

Large medical device manufacturer with a reproductive health division offering ART products including cryopreservation devices. Broad incumbent serving fertility clinics alongside many other medical specialties, competing with Cryotec in select ART device categories.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cryotec Global

Reproductive Medicine Cryopreservationcryotec.com

Cryotec Global (DBA: REPROLIFE Inc.) is a Japanese company that develops vitrification and warming technology for oocyte and embryo cryopreservation, selling a tiered Cryotec product line directly to fertility clinics worldwide.

What Cryotec Global does

Cryotec Global, operating commercially as REPROLIFE Inc., is a Japanese-based company that develops and commercializes vitrification and warming technology for oocyte and embryo cryopreservation in the assisted reproductive technology (ART) market. Its core technology is built on proprietary vitrification/warming protocols originated by Dr. Masashige Kuwayama, and is delivered through a tiered product line: the original Cryotec system, a Ready-to-Use (RtU) consumable variant launched in September 2022, and Cryotec Pro, a premium upgrade launched at ESHRE 2025 in June 2025. The company also publishes comparative clinical evidence, most notably a study reporting a 52.55% pregnancy rate versus 48.99% for a competing brand across 1,041 embryos at 13 Japanese clinics.

The company operates a B2B go-to-market model, selling devices and consumables to fertility clinics worldwide, with stated distribution or commercial coverage across seven major global regions. Its commercial motion is heavily conference-driven, with recurring presence at ESHRE, ASRM, and MEFS, and an explicit "Challenge 100" clinic-acquisition initiative suggesting an active push to broaden adoption. There is no disclosed revenue, funding, headcount, M&A activity, or senior leadership change, and no AI/ML components are integrated into the product offering. The commercial story is therefore one of a focused, founder-led ART consumables/device vendor expanding product tier and international reach on a relatively narrow financial footprint.

Cryotec Global firmographics

Firmographics
Name
Cryotec Global
Legal name
Reprolife Inc.
Website
https://cryotec.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Cryotec Global (DBA: REPROLIFE Inc.) is a Japanese company that develops vitrification and warming technology for oocyte and embryo cryopreservation, selling a tiered Cryotec product line directly to fertility clinics worldwide.
Ownership category
akta.pro rank

Cryotec Global industry classification

Industry
Product category
Reproductive Medicine Cryopreservation
NAICS
Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAAALAJ
Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening)
SECONDARYHLAAAJAN
Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)

Keywords

  • Vitrification solutions
  • Embryo cryopreservation
  • Oocyte freezing kits
  • IVF lab products
  • ART cryopreservation

Cryotec Global business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Cryotec Product Sales: Sale of Cryotec vitrification and warming products including Ready to Use kits, to fertility clinics and embryology laboratories worldwide.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Cryotec Global product offering

Product offering

Core offering

Cryotec Global develops and sells proprietary vitrification and warming kits for the cryopreservation of oocytes and embryos used by fertility clinics, IVF centers, and embryology laboratories. Its flagship Cryotec Ready to Use (RtU) line features pre-dispensed, low-toxicity cryoprotectant solutions and a unified protocol applicable to cells of any stage, with clinical data demonstrating higher pregnancy rates than competing products.

Product overview

Cryotec Global, through its brand Reprolife, offers a unified product portfolio centered on the Cryotec vitrification and warming method for reproductive cells. The core offering includes the Cryotec method/product line, Cryotec Ready to Use (RtU) kits with pre-dispensed solutions, and Cryotec Pro. These products share a unified protocol that applies to oocytes and embryos at any stage, featuring simplified procedures and high survival rates. The portfolio is designed to serve embryologists in fertility clinics worldwide, with clinical validation data demonstrating superior pregnancy outcomes compared to competing solutions.

Differentiator

Problem solved

Functional benefit

Brands

  • Cryotec RtU: Cryotec Ready to Use - vitrification and warming kits for oocytes and embryos featuring pre-dispensed solutions and simplified protocols.
  • Cryotec Pro

Products and services

  • Cryotec Cryotec is an innovative vitrification and warming method and product line for oocytes and embryos, featuring simplified protocols, embryologist-friendly product designs, and a unified protocol applicable to cells of any stage. It is developed for fertility clinics and embryology laboratories.
  • Cryotec Ready to Use (RtU) Cryotec Ready to Use is a pre-dispensed vitrification and warming kit that eliminates the need for manual solution preparation. Clinical data from 13 clinics in Japan (September 2022 - April 2024) demonstrated a 52.55% pregnancy rate compared to 48.99% with competing products, a 3.56 percentage point improvement. It targets fertility clinics, IVF centers, and embryology laboratories.
  • Cryotec Pro Cryotec Pro is an advanced Cryotec product line for reproductive cryopreservation, announced and showcased at ESHRE 2025 in Paris. Specific features and capabilities were not detailed in the source material.

Quantifiable outcome

  • Cryotec Ready to Use achieved 52.55% pregnancy rate vs 48.99% for competing brand (3.56 percentage point improvement) in study of 1,041 embryos across 13 Japanese clinics

Companies that use Cryotec Global

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Cryotec Global technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Cryotec Global partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Cryotec Global competitors and assessment

Company assessment

Broad incumbents

  • FUJIFILM Irvine Scientific: Major manufacturer of IVF/ART media, including cryopreservation solutions, as part of a much broader cell culture and bioprocessing portfolio. Competes with Cryotec in vitrification media while serving adjacent markets with greater scale.
  • CooperSurgical: Large women's health and fertility company offering ART consumables, devices, and genomics services to clinics globally. Overlaps with Cryotec in fertility clinic consumables but operates as a broad incumbent across multiple reproductive medicine categories.
  • Cook Medical: Large medical device manufacturer with a reproductive health division offering ART products including cryopreservation devices. Broad incumbent serving fertility clinics alongside many other medical specialties, competing with Cryotec in select ART device categories.

Emerging players

  • Rocket Medical: UK-based manufacturer of ART devices and consumables including embryo transfer and cryopreservation products. Comparable as a niche ART equipment supplier targeting the same fertility clinic customer base with adjacent device offerings.

Direct peers

  • Hamilton Thorne: Provider of precision instruments, consumables, and software for the ART and reproductive medicine market. Overlaps with Cryotec in serving embryologists and IVF clinics with workflow tools, though more focused on laser and imaging instruments.
  • Kitazato Corporation: Japan-based developer of the Cryotop vitrification method, the most widely used oocyte and embryo cryopreservation system globally. Direct competitor in ART cryopreservation consumables with similar target customers and product category.
  • Genea Biomedx: Australian-based ART device and consumables company offering products including vitrification tools for fertility clinics. Direct competitor targeting the same embryologist customer base with workflow-focused ART solutions.
  • Vitrolife: Swedish IVF media and cryopreservation solutions provider serving fertility clinics worldwide. Competes directly with Cryotec in vitrification and warming media for oocytes and embryos, with a broader portfolio across the IVF workflow.
  • Gynemed: German manufacturer of ART media and cryopreservation solutions for IVF clinics. Direct competitor offering comparable vitrification and warming products to the same embryologist customer segment, particularly strong in Europe.
  • LifeGlobal Group: Provider of IVF media, including vitrification solutions, sold to fertility clinics worldwide. Competes directly with Cryotec in oocyte and embryo cryopreservation media, with comparable single-use kit offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Cryotec Global social profiles

Digital presence

Cryotec Global financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cryotec Global leadership team

Management profile

Number of profiles

Profiles1 record

Cryotec Global funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cryotec Global M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cryotec Global

What does Cryotec Global do?

Cryotec Global develops and sells proprietary vitrification and warming kits for the cryopreservation of oocytes and embryos used by fertility clinics, IVF centers, and embryology laboratories. Its flagship Cryotec Ready to Use (RtU) line features pre-dispensed, low-toxicity cryoprotectant solutions and a unified protocol applicable to cells of any stage, with clinical data demonstrating higher pregnancy rates than competing products.

Is Cryotec Global a public or private company?

Cryotec Global is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Cryotec Global founded?

Cryotec Global was founded in -1. It employs 1 to 10 people.

How does Cryotec Global make money?

One revenue line is on record: cryotec Product Sales.

Who are Cryotec Global's main competitors?

Broad incumbents on record are FUJIFILM Irvine Scientific, CooperSurgical and Cook Medical. Rocket Medical is listed as an emerging player. Direct peers are Hamilton Thorne, Kitazato Corporation, Genea Biomedx, Vitrolife, Gynemed and LifeGlobal Group.

Does Cryotec Global have an API?

No public API is recorded for Cryotec Global.

What industry is Cryotec Global in?

Cryotec Global's product category is Reproductive Medicine Cryopreservation. Its primary akta.pro industry code is HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening), with a secondary code of HLAAAJAN, Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies. Its NAICS code is 325414 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales